awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33435398-E237F0D7-5C20-4924-BE56-353EB2810556
Q33435398-E237F0D7-5C20-4924-BE56-353EB2810556
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33435398-E237F0D7-5C20-4924-BE56-353EB2810556
A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis
P2860
Q33435398-E237F0D7-5C20-4924-BE56-353EB2810556
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33435398-E237F0D7-5C20-4924-BE56-353EB2810556
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7ebbef791baf369dedcdaa6c5a9da42a997a9a1f
P2860
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).